Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer Tuesday slightly raised the lower end of its full-year revenue forecast after beating Wall Street estimates for second-quarter profit, driven by strong demand for blood thinner Eliquis.